Oak Forest, ILNCT07588100Now EnrollingIRB Ready

Diabetic Retinopathy Clinical Trial in Oak Forest, IL

Access cutting-edge diabetic retinopathy treatment through this phase 1 clinical trial at a research site in Oak Forest. Study-provided care at no cost to qualified participants.

Sponsored by Hoffmann-La Roche

Quick Self-Assessment

See if you qualify for this Oak Forest location

Preparing your pre-screening questions…

Expert Care in Oak Forest

Access diabetic retinopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetic retinopathy treatment provided free

Apply for This Oak Forest Location

Check if you qualify for this diabetic retinopathy clinical trial in Oak Forest, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Oak Forest

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Oak Forest site if eligible
  4. 4Begin participation

About This Diabetic Retinopathy Study in Oak Forest

This study will assess the safety, tolerability, and pharmacokinetics (PK) of intravitreal (IVT) injections of RO7663498 in participants with diabetic retinopathy (DR).

Sponsor: Hoffmann-La Roche

Who Can Participate

Inclusion Criteria

General Inclusion Criteria
Diagnosis of Diabetes Mellitus (DM) (Type 1 or Type 2), as defined by the World Health Organization and/or American Diabetes Association Ocular Inclusion Criteria for the Study Eye
BCVA score at screening of \>= 19 letters in study eye using Early Treatment of Diabetic Retinopathy Study (ETDRS) visual acuity testing charts
Non-proliferative diabetic retinopathy (NPDR) as assessed by the investigator and confirmed by the Central reading center (CRC)
Collection of \>= 90 micro liter (μL) AH deemed feasible and safe by the investigator.

Exclusion Criteria

General Exclusion Criteria:
Any known hypersensitivity to any of the following compounds: fluorescein; any dilating, anesthetic, or povidone iodine eye drops; or any excipients contained in the treatments used in this study.
History of hypersensitivity to biologic agents, the investigational drug, or any of the excipients contained in the formulation administered IVT or systemically. Ocular Exclusion Criteria for the Study Eye
Center-involved Diabetic Macular Edema (DME)
Any history or concurrent ocular conditions/procedures and/or visual system conditions of the below.
Vitreoretinal surgery/pars plana vitrectomy.
Any history of glaucoma surgery or planned glaucoma surgery during the study.
Uncontrolled glaucoma
Anterior segment neovascularization.
Vitreous or preretinal hemorrhage.
Any ocular disease other than DR and DME that may Confound assessment of the retina in the opinion of the investigator or Confound development of worsening DR, DME, or retinal nonperfusion.
Any presence of active intraocular inflammation on Day 1 (i.e., Standardization of Uveitis Nomenclature \[SUN\] criteria \> 0 or National Eye Institute \[NEI\] vitreous haze grading \> 0) or any history of IOI.
Aphakia or previous violation of the posterior capsule in the study eye Ocular Exclusion Criteria for the Non-study Eye
BCVA \< 38 letters

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Oak Forest?

Yes, this clinical trial (NCT07588100) has an active research site in Oak Forest, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetic Retinopathy Treatment Options in Oak Forest, IL

If you're searching for diabetic retinopathy treatment options in Oak Forest, IL, this clinical trial (NCT07588100) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Oak Forest research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced diabetic retinopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetic retinopathy clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Oak Forest, IL

See all essential tremor clinical trials recruiting in Oak Forest — not just this study.

Browse Essential Tremor Trials in Oak Forest →

Browse More Trials by Condition

Essential Tremor TrialsType 2 Diabetes TrialsInterstitial Cystitis TrialsDiabetic Retinopathy TrialsAll Conditions →

Ready to Join in Oak Forest?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Oak Forest, IL